Amneal Pharmaceuticals Inc (FRA:2DT)
€ 7.7 0 (0%) Market Cap: 2.45 Bil Enterprise Value: 4.93 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 62/100

Amneal Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 07:50PM GMT
Release Date Price: €3.91 (+1.93%)
Ekaterina V. Knyazkova
JPMorgan Chase & Co, Research Division - Analyst

Good afternoon, everyone. I'm Ekaterina Knyazkova from the JPMorgan team. Pleased to be introducing Amneal. And from Amneal, we have Chirag Patel, the company's Co-Founder and co-CEO.

As a reminder, we're going to have Chirag make a presentation here, and then we'll open it up to a Q&A session. If anybody has any questions, you can ask those through the Ask A Question button on your screen.

And with that, let me turn it over to Chirag.

Chirag K. Patel
Amneal Pharmaceuticals, Inc. - Co-Founder, Co-CEO, President & Director

Thank you, Ekaterina. Good afternoon, everyone. Hopefully, everybody is safe and healthy. And we hope to come out of this COVID crisis together very soon. We thank Amneal employees who have worked very hard and -- like frontline workers during the pandemic, showing up to the labs and plants every day here in the U.S., New York, New Jersey plants, as well as India and Ireland. So we thank all our employees for excellent work in keeping the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot